12/4
03:22 pm
osrh
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement [Yahoo! Finance]
Low
Report
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement [Yahoo! Finance]
12/3
04:32 pm
osrh
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/3
04:51 am
osrh
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months [Yahoo! Finance]
High
Report
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months [Yahoo! Finance]
12/2
09:53 am
osrh
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
Low
Report
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
12/1
04:11 pm
osrh
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 [Yahoo! Finance]
Medium
Report
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025 [Yahoo! Finance]
12/1
03:01 pm
osrh
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
Medium
Report
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
11/27
02:52 pm
osrh
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
OSR (NASDAQ:OSRH) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/22
02:26 am
osrh
Cancer Immunotherapy Microcap Soars on Possible Major Licensing Deal [Globe and Mail, The (Toronto, Canada)]
Low
Report
Cancer Immunotherapy Microcap Soars on Possible Major Licensing Deal [Globe and Mail, The (Toronto, Canada)]
11/21
09:20 am
osrh
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones
High
Report
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones
11/14
11:22 am
osrh
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion [Yahoo! Finance]
Medium
Report
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion [Yahoo! Finance]
11/14
11:10 am
osrh
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
Medium
Report
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
11/6
08:30 am
osrh
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
Low
Report
OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
10/18
01:31 am
osrh
High
Report
10/14
08:30 am
osrh
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
High
Report
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
9/23
12:18 pm
osrh
Innovate GBM's 2025 Investment Playbook Year to Date Review: Building a New Market for Brain Cancer Investments and Breakthroughs [Yahoo! Finance]
Low
Report
Innovate GBM's 2025 Investment Playbook Year to Date Review: Building a New Market for Brain Cancer Investments and Breakthroughs [Yahoo! Finance]
9/9
05:54 pm
osrh
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity [Yahoo! Finance]
Low
Report
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity [Yahoo! Finance]
9/9
05:30 pm
osrh
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity
Low
Report
OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity